What AI says about Talus Bio

Talus Bio's platform measures and modulates the regulome—the body's control center for gene expression—in its native cellular context using AI-designed chemical libraries and functional proteomics. The company is developing a pipeline of first-in-class programs targeting transcription factors, cofactors, and splicing regulators for oncology, rare disease, and immune dysfunction.